Lake forest health and fitness: FDA Approves New Drug for Chronic Lymphocytic Leukemia in Patients with a Specific Chromosomal Abnormality

Friday 20 May 2016

FDA Approves New Drug for Chronic Lymphocytic Leukemia in Patients with a Specific Chromosomal Abnormality

Source: Food and Drug Administration
Related MedlinePlus Page: Chronic Lymphocytic Leukemia via MedlinePlus Health News Read More Here..

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)